Skip to main content
HCWB
NASDAQ Life Sciences

HCW Biologics Raises Up to $10M in Secured Debt From Streeterville Capital

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.09
Mkt Cap
$2.415M
52W Low
$1.08
52W High
$23.94
52W Position info
0.9% above low
Off High info
95% below high
Rel. Volume
Market data snapshot near publication time

HCWB is trading near its 52-week low of $1.08 (0.9% above the low).

Summary

HCW Biologics closed a $10.0 million secured debt financing with Streeterville Capital — $3.0 million in cash now and $7.0 million held in a lender-controlled account released as the first note is repaid. The money is earmarked to finish the HCW9302 Phase 1 study, but the terms are expensive and the company remains cash-constrained.


Key Events · Financing and Capital Events · HCWB

  • Up to $10M Secured Debt Closed

    On November 3, 2026, HCW Biologics signed a Notes Purchase Agreement with Streeterville Capital covering a $3.24 million A-1 Note and a $7.0 million B Note; the deal closed November 4, 2026.

  • Only $3.0M Cash at Closing

    Net cash to the company was $2.97 million — the lender paid $3.0 million less $30,000 of transaction costs. The $7.0 million B Note sits in an HCWB Holdings deposit account under a control agreement and is released only as the B Note is exchanged for A Notes.

  • Expensive Terms and Penalties

    The A-1 Note carries 8% interest and a $240,000 original issue discount. If it is still outstanding after 90 days, a monitoring fee equal to the balance divided by 0.85 minus the balance is added; trigger events can raise the balance by 10% (major) or 5% (minor), with 15% default interest.

  • Subsidiary Pledged as Collateral

    Collateral includes 100% of the membership interests in newly formed HCWB Holdings, LLC, which also guarantees the notes; covenants bar new variable-rate debt and other liens without lender consent.


Analysis · HCWB · Life Sciences

Survival is the first order of business here: HCW Biologics had $741,324 in cash and a going-concern warning as of its last 10-Q. The deal delivers $3.0 million now, with a further $7.0 million available only as the first note is paid down — the second note sits in a locked account the lender controls. And the cost is steep: 8% interest on the A-1 Note, a $240,000 original issue discount, a monitoring fee that adds roughly 17.6% to the balance if the note is still outstanding after 90 days, and 10%/5% balance penalties on trigger events. Collateral covers 100% of the membership interests in the new HCWB Holdings subsidiary, and covenants bar other variable-rate debt without lender consent. Management says the money funds completion of the HCW9302 Phase 1 alopecia areata study and the Recommended Phase 2 Dose, expected in the first quarter of 2027.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HCWB was trading at $1.09 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.4M. The 52-week trading range was $1.08 to $23.94. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HCWB - Latest Insights

HCWB
Nov 18, 2026, 5:24 PM EST
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.7639
Real-time Price: $0.720 info
Change: -$0.0439 (-6%) info
Market Cap: $2.308M info
HCWB
Nov 16, 2026, 8:30 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.780
Real-time Price: $0.720 info
Change: -$0.060 (-8%) info
Market Cap: $2.308M info
HCWB
Nov 16, 2026, 8:30 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.780
Real-time Price: $0.720 info
Change: -$0.060 (-8%) info
Market Cap: $2.308M info
HCWB
Nov 16, 2026, 8:15 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.780
Real-time Price: $0.720 info
Change: -$0.060 (-8%) info
Market Cap: $2.308M info
HCWB
Nov 05, 2026, 8:45 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.16
Real-time Price: $0.720 info
Change: -$0.440 (-38%) info
Market Cap: $2.308M info